CEO Dr. Raza Bokhari talked with Proactive about the company’s newly reported topline Phase 2 results for its microneedle ...

A prospective cohort study published in Nature Communications reports that a second pregnancy is associated with distinct structural and functional brain changes on MRI, differing in key ways from ...

For decades, engineering entrance examinations served simply as academic gateways to prestigious institutions. They have now evolved into something much more important: tools that predict how ...

The company expects to initiate the 12-week Phase II ARCT-032 study in the first half of 2026, enrolling up to 20 participants and focusing on safety and early signs of clinical benefit. For ARCT-810, ...

Announced data from cohort 4 of soquelitinib atopic dermatitis Phase 1 trial demonstrating positive safety and efficacy results, including in ...

A 10-year Danish study finds puberty is starting earlier in kids, linking the shift to pregnancy, weight, stress, and genetics.

Most talent strategies plan Boomer-to-Gen-X transitions. The actual handoff? Jones-to-Millennial. The generational map is wrong.

A quiet warning signal for Crohn’s disease may show up in your blood years before your stomach ever hurts. That is the message from new research out of Sinai Health, where scientists report a blood ...

(OTC: HPNN), through its subsidiary Digitalage, today announced that its live streaming platform and Newsroom OS journalism intelligence system have entered controlled production deployment — with ...

AMT-130 Huntington’s gene therapy data, FDA Phase III sham-trial push, cash runway, and 2026 catalysts—read now.

Planned submission for U.S. Accelerated Approval of z-rostudirsen on track for Q2 2026; potential launch in Q1 2027 - - Positive topline results reported from Phase 1/2 DELIVER trial of z-rostudirsen ...

CEO to Discuss INTASYL Platform and PH-762 Phase 1b Results King of Prussia, Pennsylvania--(Newsfile Corp. - March 5, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA ...